HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

triclabendazole sulfoxide

Also Known As:

6-Chloro-5-(2,3-dichlorophenoxy)-2-(methylsulfinyl)-1H-benzimidazole; TCBZ-SX; 1H-Benzimidazole, 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylsulfinyl)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzimidazoles: 245
      - Triclabendazole: 215
        triclabendazole sulfoxide: 1
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Sulfoxides: 23
    - triclabendazole sulfoxide: 1

Experts

1.	Barenys, Marta: 1 article (01/2015)
2.	Boix, Nuria: 1 article (01/2015)
3.	Ibáñez, Elena: 1 article (01/2015)
4.	Llobet, Juan M: 1 article (01/2015)
5.	Ortiz, Pedro: 1 article (01/2015)
6.	Teixido, Elisabet: 1 article (01/2015)
7.	Vila-Cejudo, Marta: 1 article (01/2015)

Related Diseases

1.	Paragonimiasis 01/01/2015 - "In humans, after ingestion of the recommended doses of triclabendazole to treat fascioliasis and paragonimiasis (10 mg/kg), the main compound found in plasma is triclabendazole sulfoxide (maximum concentration 38.6 μM), while triclabendazole concentrations are approximately 30 times lower (1.16 μM). "
2.	Fascioliasis 01/01/2015 - "In humans, after ingestion of the recommended doses of triclabendazole to treat fascioliasis and paragonimiasis (10 mg/kg), the main compound found in plasma is triclabendazole sulfoxide (maximum concentration 38.6 μM), while triclabendazole concentrations are approximately 30 times lower (1.16 μM). "

Related Drugs and Biologics

1.	Triclabendazole